PARP inhibitors synergize with gemcitabine by potentiating DNA damage in non-small-cell lung cancer

International Journal of Cancer. Journal International Du Cancer
Yu JiangDaniel J McGrail

Abstract

Poly (ADP-ribose) polymerase (PARP) inhibitors have demonstrated great promise in the treatment of patients with deficiencies in homologous recombination (HR) DNA repair, such as those with loss of BRCA1 or BRCA2 function. However, emerging studies suggest that PARP inhibition can also target HR-competent cancers, such as non-small-cell lung cancer (NSCLC), and that the therapeutic effect of PARP inhibition may be improved by combination with chemotherapy agents. In our study, it was found that PARP inhibitors talazoparib (BMN-673) and olaparib (AZD-2281) both had synergistic activity with the common first-line chemotherapeutic gemcitabine in a panel of lung cancer cell lines. Furthermore, the combination demonstrated significant in vivo antitumor activity in an H23 xenograft model of NSCLC compared to either agent as monotherapy. This synergism occurred without loss of HR repair efficiency. Instead, the combination induced synergistic single-strand DNA breaks, leading to accumulation of toxic double-strand DNA lesions in vitro and in vivo. Our study elucidates the underlying mechanisms of synergistic activity of PARP inhibitors and gemcitabine, providing a strong motivation to pursue this combination as an improved therapeutic...Continue Reading

References

Jun 1, 1993·British Journal of Cancer·D P Gately, S B Howell
Oct 1, 1995·Trends in Biochemical Sciences·D B Zamble, S J Lippard
Jul 27, 2002·Science·John Rouse, Stephen P Jackson
Dec 10, 2003·Oncogene·Deepa SampathWilliam Plunkett
Dec 17, 2005·Cell Cycle·You-Wei ZhangRobert T Abraham
Mar 30, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Thomas BrodowiczUNKNOWN Central European Cooperative Oncology Group CECOG
Jun 30, 2006·Annual Review of Genetics·Jacob C Harrison, James E Haber
Jul 13, 2007·Nature Reviews. Cancer·Lloyd Kelland
Feb 8, 2008·Nature Reviews. Cancer·Thomas HelledayRicky A Sharma
Jul 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan Ashworth
Apr 11, 2009·Nature·Michael R StrattonP Andrew Futreal
Apr 14, 2009·Free Radical Biology & Medicine·Andreína Peralta-LealF Javier Oliver
Oct 23, 2009·Nature·Stephen P Jackson, Jiri Bartek
Jul 27, 2010·Lancet·Stephen L Chan, Tony Mok
Jun 28, 2011·Nature Medicine·Neil JohnsonGeoffrey I Shapiro
Jan 20, 2012·Nature·Christopher J Lord, Alan Ashworth
Mar 6, 2012·Nature Structural & Molecular Biology·Arnab Ray ChaudhuriMassimo Lopes
Aug 25, 2012·Nature Reviews. Cancer·Peter Bouwman, Jos Jonkers
Nov 24, 2012·Nature Reviews. Cancer·Nicola J Curtin
Feb 6, 2013·Cancer Biology & Therapy·Derek Woods, John J Turchi
Oct 1, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert J CardnellLauren A Byers
Feb 21, 2014·Nature Communications·Guang PengShiaw-Yih Lin
Aug 17, 2014·Journal of the National Cancer Institute·Mustafa RaoofSteven A Curley
Apr 9, 2015·Frontiers in Genetics·Małgorzata KrajewskaMarcel A T M van Vugt
Nov 8, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wei MoShiaw-Yih Lin
May 28, 2016·Gynecologic Oncology Research and Practice·Robert S Meehan, Alice P Chen
Jul 22, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Benjamin H LokCharles M Rudin
Dec 9, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Qipeng XieYu Liu

❮ Previous
Next ❯

Citations

Aug 8, 2019·DNA Repair·Jennifer KayBevin Engelward
Dec 20, 2020·Cancer Genetics·Larissa Costa de AlmeidaLeticia Veras Costa-Lotufo
Mar 21, 2021·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Fabio AimiMichael O Hottiger
Aug 27, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suresh S RamalingamJulien Mazieres

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Related Papers

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
David R Spigel
Clinical Advances in Hematology & Oncology : H&O
Ruth Plummer
Current Problems in Cancer
Yvonne L E Ang, David S P Tan
Expert Opinion on Investigational Drugs
Jordi RodonKyriakos Papadopoulos
© 2022 Meta ULC. All rights reserved